Biovista Pvt Ltd

The Natural Cholestrol Reducer

Cholesterol Control, a Challenging Task.
Hypercholesterolemia is a widespread problem and a big challenge for healthcare professionals these days. They have to keep cholesterol at desirable levels while ensuring safety of their patients for a long period. This becomes a difficult task as the commonly used treatments are not safe, especially in long-term use.

The Role of COLESTOCARE® (Policosanol).
COLESTOCARE® ( Policosanol), a novel cholesterol lowering agent not only promises to be at least as effective as statins, but in several studies has shown no negative effect of any clinical or laboratory parameter. Policosanol (COLESTOCARE®) has recently been one of the most widely researched molecule and the clinical data already available makes it one of the most promising new discoveries.

Policosanol (COLESTOCARE® ) Post- Marketing Surveillance.
Tolerability of Policosanol (COLESTOCARE®) was assessed in 27,879 patients (17,225 patients for two years and 10,654 patients for four years).
During the study, 86 patients (0.31%) reported adverse effects, the most frequent of which was weight loss.
A single dose (1,000 mg/day) as much as 50 times the maximum recommended dose (20 mg/day) administered to healthy volunteers produced no adverse reaction.

Fernandez L., et al (1998): Curr. Ther. Res. 59:7717-22.

Policosanol (COLESTOCARE®) Effective & Safer than Statins.
From comparative studies it can be concluded that 10 mg of Policosanol (COLESTOCARE®) is equivalent in efficacy to lovastatin 20 mg, pravastatin 10 mg, & simvastatin 10 mg. While these drugs have well-known side effects, Policosanol (COLESTOCARE®) is completely safe.

Canetti M. et al. (1995): Intern. J. Clin. Pharmacol. Res. 15:159-165.

Cholesterol Reducing Ability and Results in Long Term Use with Policosanol (COLESTOCARE®).

At a daily dosage of 10 mg of Policosanol (COLESTOCARE®), LDL levels typically drop by 20 to 25% within the first six months. At a dosage of 20 mg, LDL levels typically drop by 25-30%. HDL cholesterol levels typically increase by 15 to 25% after only two months of use.

Pons P. et al. (1994): J. Clin. Pharmacol.
Canetti M. et al. (1995): Intern. J. Clin. Pharmacol. Res. 15:159-165.

Policosanol (COLESTOCARE® ) Compared to Atorvastatin.

G, Mas R, et al. Drugs Aging 2003;20 (2):153-63.


		The Natural Cholestrol Reducer Cholesterol Control, a Challenging Task. Hypercholesterolemia is a widespread problem and a big challenge for healthcare professionals these days. They have to keep cholesterol at desirable levels while ensuring safety of their patients for a long period. This becomes a difficult task as the commonly used treatments are not safe, especially in long-term use. The Role of COLESTOCARE® (Policosanol). COLESTOCARE® ( Policosanol), a novel cholesterol lowering agent not only promises to be at least as effective as statins, but in several studies has shown no negative effect of any clinical or laboratory parameter. Policosanol (COLESTOCARE®) has recently been one of the most widely researched molecule and the clinical data already available makes it one of the most promising new discoveries. Policosanol (COLESTOCARE® ) Post- Marketing Surveillance. Tolerability of Policosanol (COLESTOCARE®) was assessed in 27,879 patients (17,225 patients for two years and 10,654 patients for four years). During the study, 86 patients (0.31%) reported adverse effects, the most frequent of which was weight loss. A single dose (1,000 mg/day) as much as 50 times the maximum recommended dose (20 mg/day) administered to healthy volunteers produced no adverse reaction. Fernandez L., et al (1998): Curr. Ther. Res. 59:7717-22.

	Policosanol (COLESTOCARE®) Effective & Safer than Statins. From comparative studies it can be concluded that 10 mg of Policosanol (COLESTOCARE®) is equivalent in efficacy to lovastatin 20 mg, pravastatin 10 mg, & simvastatin 10 mg. While these drugs have well-known side effects, Policosanol (COLESTOCARE®) is completely safe. Canetti M. et al. (1995): Intern. J. Clin. Pharmacol. Res. 15:159-165. Cholesterol Reducing Ability and Results in Long Term Use with Policosanol (COLESTOCARE®). At a daily dosage of 10 mg of Policosanol (COLESTOCARE®), LDL levels typically drop by 20 to 25% within the first six months. At a dosage of 20 mg, LDL levels typically drop by 25-30%. HDL cholesterol levels typically increase by 15 to 25% after only two months of use. Pons P. et al. (1994): J. Clin. Pharmacol. Canetti M. et al. (1995): Intern. J. Clin. Pharmacol. Res. 15:159-165.	Policosanol (COLESTOCARE® ) Compared to Atorvastatin. G, Mas R, et al. Drugs Aging 2003;20 (2):153-63.